Trial Profile

ORODISPERSIBLE MINITABLETS OF ENALAPRIL IN YOUNG CHILDREN WITH HEART FAILURE DUE TO CONGENITAL HEART DISEASE

Status: Not yet recruiting

Phase of Trial: Phase II/III

Latest Information Update: 22 Jul 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Enalapril (Primary)
Indications Congenital heart defects; Heart failure
Focus Pharmacokinetics
Acronyms LENA-WP09
Sponsors Ethicare GmbH

Most Recent Events

01 Jul 2019 This trial has been Discontinued in UK - MHRA, according to European Clinical Trials Database.
01 Jul 2019 This trial has been Discontinued in UK - MHRA, according to European Clinical Trials Database.
26 Sep 2018 The trial has been completed in Austria (End Date;2018-05-17).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com